The development and preliminary validation of a scale measuring the impact of syncope on quality of life

Europace

Volumn 11, Issue 10, 2009, Pages 1369-1374

  Rose, Marianne Sarah ^a   Koshman, Mary Lou ^a   Ritchie, Debbie ^a   Sheldon, Robert ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clinical impact; Construct validity; Convergent validity; Health related quality of life; Syncope

Indexed keywords

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONTENT VALIDITY; DEPRESSION; FEAR; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SYNCOPE; SYNCOPE FUNCTIONAL STATUS QUESTIONNAIRE;

ADULT; CANADA; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNCOPE;

EID: 70349514916     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup106     Document Type: Article

References (28)

1. Rose MS, Koshman ML, Spreng S, Sheldon R. The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol 2000;53:1209-1216
2. Rose MS, Koshman ML, Spreng S, Sheldon R. Statistical issues encountered in the comparison of health-related quality of life in diseased patients to published general population norms: problems and solutions. J Clin Epidemiol 1999;52: 405-412
3. Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB. Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med 1994;9:181-186
4. van Dijk N, Boer KR, Weiling W, Linzer M, Sprangers MA. Reliability, validity and responsiveness of the Syncope Functional Status Questionnaire. J Gen Int Med 2007;22:1280-1285
5. Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997;50:233-238
6. Sheldon R, Rose S, Ritchie D, Connolly SJ, Koshman ML, Lee MA et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol 2002;40:142-148
7. Sheldon RS, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M. Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 2006; 27:344-350
8. Jacobson GP, Ramadan NM, Aggarawal SK, Newman CW. The Henry Ford headache disability inventory (HDI). Neurology 1994;44:837-842
9. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83.
10. Devinsky O, Vickrey BG, Cramer J, Perrine K, Hermann B, Meador K et al. Development of the quality of life in epilepsy inventory. Epilepsia 1995;36:1089-1104
11. Feinstein AR. Clinimetrics. New Haven: Yale University Press; 1987.
12. Charlson ME, Pompeii P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-383
13. Charlson M, Sztrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251
14. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
15. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 1998; 316:736-741
16. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-410.
17. Weissman MM, Sholomskas D, Pottenger MM, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203-214
18. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. Oxford: Oxford University Press; 1996.
19. Sheldon RS, Sheldon AG, Serletis A, Connolly SJ, Morillo CA, Klingenheben T et al. for the Investigators of the Prevention Of Syncope Study. Worsening of symptoms before presentation with vasovagal syncope. J Cardiovasc Electrophysiol 2007;18:954-959
20. Portney, Leslie G, Watkins MP. Foundations of Clinical Research: Applications to practice. 2nd ed. New Jersey: Prentice Hall Health; 2000.
21. Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006;113:1164-1170
22. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;5:887-900.
23. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Medical Care 1989;27:S217-S232.
24. Weibe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003;56: 52-60.
25. Rutishauser C, Sawyer SM, Bond L, Cofey C, Bowes G. Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL). Eur Resp J 2001;17:52-58
26. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58:339-343
27. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. The Sarcidosis Health Questionnaire. Am J Resp Crit Care Med 2003;168:323-329
28. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. Massachusetts: The Health Institute; 1993.